|
|
|
HINJ IN ACTION
TRUSTEE UPDATE
September 10, 2008 Volume 1, Issue 1
|
|
Alpharma, Dean Mitchell●Amicus Therapeutics, John F. Crowley ●BD, Edward Ludwig●Baxter Healthcare● Bayer HealthCare Pharmaceuticals, Reinhard Franzen● Bristol Myers Squibb, Dick Thompson●C.R. Bard, Timothy Ring●Catalent Pharma Solutions, John Lowry●Celgene Corporation, Bob Hugin●Cherokee Pharma, John Elliott●Daiichi Sankyo, Joseph Pieroni● Eisai Inc., Hajime Shimizu●GlaxoSmithKline, Janie Kinney● Hoffmann-LaRoche, George Abercrombie● Johnson & Johnson, Cliff Holland● LTS Lohmann Therapy Systems, Benoit Cossart●Medarex, Howard Pien● Merck & Co., Inc., Willie Deese● Millenium Pharmaceuticals, Michael Eging●Novartis Pharmaceuticals Corp., Kevin Rigby● Novo Nordisk, James Shehan● Pfizer Inc., Richard Bagger● Reckitt Benckiser NAA, Dave Long●sanofi-aventis, Tim Rothwell● Schering-Plough Corp., Fred Hassan● Stryker Corp, Ned Lipes●Wyeth, Joseph Mahady
|
|
|
|
|
|
PFCD-NJ OFFICIALLY LAUNCHES!
The Partnership to Fight Chronic Disease (PFCD-NJ) officially launched Tuesday with events keynoted by Richard H. Carmona, M.D., former U.S. Surgeon General and chairperson of the Partnership to Fight Chronic Disease. Former Governor Jim Florio and David Knowlton, President and CEO of the NJ Health Care Quality Institute, were named chairs of the PFCD-NJ effort.
PFCD-NJ was rolled out in two press conferences - one in East Brusnwick and the second at Cooper Medical Center in Camden.
To date, over 75 patient assistance groups and organizations have signed on as partners of PFCD-NJ.
In July, Ross DeVol, director of health economics at the Milken Institute, presented the findings of the Milken Study, which details the economic impact of chronic disease - nationally and in NJ.
To learn more, visit:
www.fightchronicdisease.org
| |
|
|
|
Welcome to the first issue of Trustee Update, which is designed exclusively for Trustees of the HealthCare Institute of New Jersey. Each month, you'll be receiving an update that provides a quick snapshot of the biopharmaceutical sector's activities - both here and in Washington. Because our industry's work is about improving and enhancing the quality of life for patients, we'll feature HINJ outreach activities to patients,health care organizations, opinion leaders and policy makers. We hope you enjoy this inaugural issue.
|
|
|
|
How Will the Presidential Candidates' Health Care Plans Impact our Industry?
Senior Health Care Aides to Obama and McCain Explain
In July, HINJ co-sponsored a program at the Rutgers Business School featuring David Cutler, PhD., senior health care advisor to Sen. Barrack Obama and Gail Wilensky, PhD., senior health care advisor to Sen. John McCain. The two advisors presented their candidate's health care plans at the 4th Annual Lerner Center Symposium. The program was moderated by
Susan Dentzer, of PBS' The NewsHour with Jim Lehrer.
Here's what they said:
David Cutler:
"I think that any kind of health reform like what Sen. Obama has proposed would actually be very good for the pharmaceutical industry. And here's the reason why. The basic fact about preventive care and chronic care management is that people don't get enough of it. Well, an enormous part of the management of that is pharmaceuticals. And so just to give you a sense how bad it is, roughly one-third of people with high cholesterol have it successfully treated. And one-third of people with high blood pressure have it successfully treated. And one-third of people with depression have it successfully treated. So basically what we're looking at is markets that are at least two-thirds underdeveloped.
And so if you have a medical system that stresses prevention, that stresses care management, that stresses caring for people before they get very sick that has got to be a huge windfall to everyone in that space. I don't worry for a minute that anything in there would be that bad for the pharmaceutical industry."
Susan Dentzer:
"Let's remember the whole point of drug importation is in essence to piggy back on other countries price control regimes or price reduction regimes and lower the price."
Gail Wilensky (responding to Dentzer):
"No it's not. No, no. It's to go to a single price. Anybody who thinks that's the only outcome ought to follow some of what happened when Medicaid best price came into effect. Some of the prices went down and the lowest prices were driven up."
To learn more about the candidate's health care plans, visit: 4th Annual Lerner Center Symposium |
|
2008 Deloitte/HINJ Economic Study: Congressional Candidates Participate in Roll-Out
WHAT
Annual Release of HINJ Economic Impact Study and Press Conferences
WHERE
Alpharma, Bridgewater and Catalent, Moorestown
WHEN
Monday, August 18, 2008
WHO
· 7th Congressional District Republican Candidate, Senator Leonard Lance
7th Congressional District Democratic Candidate, Assemblywoman Linda Stender
· 3rd Congressional District Republican Candidate, Chris Myers
· Dr. James Hughes, Dean of the Bloustein School of Public Policy at Rutgers
· Mr. Patrick O'Keefe, Director of the Research Division of J.H. Cohen
FAST FACTS:
Highlights from the
2008 HINJ Economic Survey :
- HINJ members had a $27 billion economic impact on NJ in 2007, up from $26 billion last year.
- In 2007, HINJ member jobs accounted for an aggregate payroll of $7.7 billion. New Jersey residents held 85 percent of these jobs.
- The industry was responsible for 82,000 spin-off jobs in 2007.
For more information and to review the press release and study, visit: www.hinj.org
|
|
 Congressman Frank Pallone is Special Guest at HealthCare Institute of New Jersey's 'Healthy Living: Health and Wellness Fair'
WHAT
Healthy Living: Health and Wellness Fair
WHERE
Riverview Medical Center in Red Bank
WHEN
Monday, August 18, 2008
WHO
Congressman Frank Pallone, Jr. (D-NJ).
250 patients
Pharmaceutical Research and Manufacturers of America
Johnson & Johnson
Merck
Novo Nordisk
Wyeth
For more information, visit: www.riverviewmedicalcenter.com or
 |
|
|
|
|
|
|
|
|
